{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T05:13:48Z","timestamp":1736226828813,"version":"3.32.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2000,11,1]],"date-time":"2000-11-01T00:00:00Z","timestamp":973036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2000,11,1]],"date-time":"2000-11-01T00:00:00Z","timestamp":973036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2000,11]]},"DOI":"10.1136\/ard.59.suppl_1.i72","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T10:40:22Z","timestamp":1027766422000},"page":"i72-i74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"S1","title":["The final pathogenetic steps in focal bone erosions in rheumatoid arthritis"],"prefix":"10.1016","volume":"59","author":[{"given":"Steven R","family":"Goldring","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ard.59.suppl_1.i72_bib1","series-title":"Metabolic bone disease 2nd ed.","first-page":"621","article-title":"Bone disease in rheumatological disorders.","author":"Goldring","year":"1998"},{"key":"10.1136\/ard.59.suppl_1.i72_bib2","series-title":"Dynamics of bone and cartilage metabolism.","first-page":"623","article-title":"Rheumatoid arthritis and other inflammatory joint pathologies. Siebel MJ, Robin SP, Bilezikian JP, eds.","author":"Goldring","year":"1999"},{"key":"10.1136\/ard.59.suppl_1.i72_bib3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/ar67","article-title":"Mechanisms of bone loss in inflammatory arthritis: diagnosis and therapeutic implications.","volume":"2","author":"Goldring","year":"2000","journal-title":"Arthritis Res"},{"key":"10.1136\/ard.59.suppl_1.i72_bib4","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/00002281-200005000-00006","article-title":"Pathogenesis of bone erosions in rheumatoid arthritis.","volume":"12","author":"Goldring","year":"2000","journal-title":"Curr Opin Rheumatol"},{"key":"10.1136\/ard.59.suppl_1.i72_bib5","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1136\/ard.44.9.580","article-title":"Bone turnover in early rheumatoid arthritis; longitudinal bone density studies.","volume":"44","author":"Sambrook","year":"1985","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.59.suppl_1.i72_bib6","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1136\/ard.45.11.950","article-title":"Osteoporosis in rheumatoid arthritis: safety of low dose corticosteroids.","volume":"45","author":"Sambrook","year":"1986","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.59.suppl_1.i72_bib7","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/art.1780300701","article-title":"Determinants of axial bone loss in rheumatoid arthritis.","volume":"30","author":"Sambrook","year":"1987","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.59.suppl_1.i72_bib8","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/rheumatology\/35.4.309","article-title":"Bone mass measurement and bone metabolism in rheumatoid arthritis: a review.","volume":"35","author":"Deodhar","year":"1996","journal-title":"Br J Rheumatol"},{"key":"10.1136\/ard.59.suppl_1.i72_bib9","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/ard.53.1.14","article-title":"Excretion of pyridinium crosslinks correlates with disease activity and appendicular bone loss in early rheumatoid arthritis.","volume":"53","author":"Gough","year":"1994","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.59.suppl_1.i72_bib10","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1002\/art.1780271205","article-title":"Fractures after rheumatoid arthritis; a population based study.","volume":"27","author":"Hooyman","year":"1984","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.59.suppl_1.i72_bib11","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/1529-0131(200003)43:3<522::AID-ANR7>3.0.CO;2-Y","article-title":"Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: results from 394 patients in the Oslo County Rheumatoid Arthritis Register.","volume":"43","author":"Haugeberg","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.59.suppl_1.i72_bib12","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/art.1780270902","article-title":"Chondroclasts and osteoclasts at subchondral sites of erosion in the rheumatoid joint.","volume":"27","author":"Bromley","year":"1984","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.59.suppl_1.i72_bib13","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1136\/ard.43.1.76","article-title":"Mast cells at sites of cartilage erosion in the rheumatoid joint.","volume":"43","author":"Bromley","year":"1984","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.59.suppl_1.i72_bib14","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/art.1780270804","article-title":"Histopathology of the rheumatoid lesion. Identification of cell types at sites of cartilage erosion.","volume":"27","author":"Bromley","year":"1984","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.59.suppl_1.i72_bib15","first-page":"943","article-title":"Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis.","volume":"152","author":"Gravallese","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1136\/ard.59.suppl_1.i72_bib16","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/1529-0131(200004)43:4<821::AID-ANR12>3.0.CO;2-T","article-title":"Expression of osteoclast differentiation factor at sites of bone erosion in collagen-induced arthritis.","volume":"43","author":"Romas","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.59.suppl_1.i72_bib17","first-page":"751","article-title":"Induction of abundant osteoclast-like multinucleated giant cells in adjuvant arthritic rats with accompanying disordered high bone turnover.","volume":"13","author":"Kuratani","year":"1998","journal-title":"Histol Histopathol"},{"key":"10.1136\/ard.59.suppl_1.i72_bib18","first-page":"1887","article-title":"Cysteine proteinase cathepsin K mRNA is expressed in synovium of patients with rheumatoid arthritis and is detected at sites of synovial bone destruction.","volume":"25","author":"Hummel","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.59.suppl_1.i72_bib19","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1210\/endo-125-3-1606","article-title":"Calcitonin receptors as markers for osteoclastic differentiation: correlation between generation of bone-resorptive cells and cells that express calcitonin receptors in mouse bone marrow cultures.","volume":"125","author":"Hattersley","year":"1989","journal-title":"Endocrinology"},{"key":"10.1136\/ard.59.suppl_1.i72_bib20","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1210\/endo-124-4-1689","article-title":"Generation of osteoclastic function in mouse bone marrow cultures: multinuclearity and tartrate-resistant acid phosphatase are unreliable markers for osteoclastic differentiation.","volume":"124","author":"Hattersley","year":"1989","journal-title":"Endocrinology"},{"key":"10.1136\/ard.59.suppl_1.i72_bib21","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1210\/endo.136.10.7664679","article-title":"Expression of the calcitonin receptor in bone marrow cell cultures and in bone: a specific marker of the differentiated osteoclast that is regulated by calcitonin.","volume":"136","author":"Lee","year":"1995","journal-title":"Endocrinology"},{"key":"10.1136\/ard.59.suppl_1.i72_bib22","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1210\/endo.135.6.7988453","article-title":"Cloning and characterization of a mouse brain calcitonin receptor complementary deoxyribonucleic acid and mapping of the calcitonin receptor gene.","volume":"135","author":"Yamin","year":"1994","journal-title":"Endocrinology"},{"key":"10.1136\/ard.59.suppl_1.i72_bib23","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1172\/JCI117970","article-title":"Expression of two human skeletal calcitonin receptor isoforms cloned from a giant cell tumor of bone.","volume":"95","author":"Gorn","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1136\/ard.59.suppl_1.i72_bib24","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/46303","article-title":"Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand.","volume":"402","author":"Kong","year":"1999","journal-title":"Nature"},{"key":"10.1136\/ard.59.suppl_1.i72_bib25","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","article-title":"Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.","volume":"89","author":"Simonet","year":"1997","journal-title":"Cell"},{"key":"10.1136\/ard.59.suppl_1.i72_bib26","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1210\/endo.139.3.5837","article-title":"Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG\/OCIF inhibits osteoclastogenesis in vitro.","volume":"139","author":"Yasuda","year":"1998","journal-title":"Endocrinology"},{"key":"10.1136\/ard.59.suppl_1.i72_bib27","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1073\/pnas.95.7.3597","article-title":"Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclastogenesis-inhibitory factor and is identical to TRANCE\/RANKL.","volume":"95","author":"Yasuda","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1136\/ard.59.suppl_1.i72_bib28","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.","volume":"93","author":"Lacey","year":"1998","journal-title":"Cell"},{"key":"10.1136\/ard.59.suppl_1.i72_bib29","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1084\/jem.186.12.2075","article-title":"TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor.","volume":"186","author":"Wong","year":"1997","journal-title":"J Exp Med"},{"key":"10.1136\/ard.59.suppl_1.i72_bib30","doi-asserted-by":"crossref","first-page":"25190","DOI":"10.1074\/jbc.272.40.25190","article-title":"TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells.","volume":"272","author":"Wong","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1136\/ard.59.suppl_1.i72_bib31","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/1529-0131(200002)43:2<250::AID-ANR3>3.0.CO;2-P","article-title":"Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor.","volume":"43","author":"Gravallese","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.59.suppl_1.i72_bib32","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1006\/bbrc.1999.1623","article-title":"Activated T lymphocytes support osteoclast formation in vitro.","volume":"265","author":"Horwood","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1136\/ard.59.suppl_1.i72_bib33","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/1529-0131(200002)43:2<259::AID-ANR4>3.0.CO;2-W","article-title":"Involvement of receptor activator of nuclear factor kappa-B ligand\/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis.","volume":"43","author":"Takayanagi","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.59.suppl_1.i72_bib34","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/rheumatology\/31.10.653","article-title":"Detection of cytokines at the cartilage\/pannus junction in patients with rheumatoid arthritis: implications for the role of cytokines in cartilage destruction and repair.","volume":"31","author":"Chu","year":"1992","journal-title":"Br J Rheumatol"},{"key":"10.1136\/ard.59.suppl_1.i72_bib35","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1146\/annurev.immunol.14.1.397","article-title":"Role of cytokines in rheumatoid arthritis.","volume":"14","author":"Feldmann","year":"1996","journal-title":"Ann Rev Immunol"},{"key":"10.1136\/ard.59.suppl_1.i72_bib36","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1093\/rheumatology\/31.12.801","article-title":"Localization of interleukin-1 alpha, type 1 interleukin-1 receptor and interleukin-1 receptor antagonist in the synovial membrane and cartilage\/pannus junction in rheumatoid arthritis.","volume":"31","author":"Deleuran","year":"1992","journal-title":"Br J Rheumatol"},{"key":"10.1136\/ard.59.suppl_1.i72_bib37","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1172\/JCI728","article-title":"Synovium as a source of increased amino-terminal parathyroid hormone-related protein expression in rheumatoid arthritis; a possible role for locally produced parathyroid hormone-related protein in the pathogenesis of rheumatoid arthritis.","volume":"101","author":"Funk","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1136\/ard.59.suppl_1.i72_bib38","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1093\/rheumatology\/35.11.1056","article-title":"Parathyroid hormone-related peptide in synovial fluid and disease activity of rheumatoid arthritis.","volume":"35","author":"Okano","year":"1996","journal-title":"Br J Rheumatol"},{"key":"10.1136\/ard.59.suppl_1.i72_bib39","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1002\/1529-0131(199812)41:12<2196::AID-ART15>3.0.CO;2-2","article-title":"Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist.","volume":"41","author":"Bresnihan","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.59.suppl_1.i72_bib40","first-page":"S117","article-title":"A phase III trial of etanercept vs methotrexate (MTX) in early rheumatoid arthritis (Enbrel ERA trial). [Abstract].","volume":"42","author":"Finck","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.59.suppl_1.i72_bib41","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/art.1780390513","article-title":"Anticytokine treatment of established type II collagen-induced arthritis in DBA\/1 mice; a comparative study using anti-TNF alpha, anti- IL-1 alpha\/beta, and IL-1Ra.","volume":"39","author":"Joosten","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.59.suppl_1.i72_bib42","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s000110050396","article-title":"Synergistic protection against cartilage destruction by low dose prednisolone and interleukin-10 in established murine collagen arthritis.","volume":"48","author":"Joosten","year":"1999","journal-title":"Inflamm Res"},{"key":"10.1136\/ard.59.suppl_1.i72_bib43","doi-asserted-by":"crossref","first-page":"478","DOI":"10.7326\/0003-4819-130-6-199903160-00004","article-title":"Etanercept therapy in rheumatoid arthritis; a randomized, controlled trial.","volume":"130","author":"Moreland","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.59.suppl_1.i72_bib44","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/S0140-6736(99)05246-0","article-title":"Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group.","volume":"354","author":"Maini","year":"1999","journal-title":"Lancet"},{"key":"10.1136\/ard.59.suppl_1.i72_bib45","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1001\/archinte.159.21.2542","article-title":"Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate.","volume":"159","author":"Strand","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1136\/ard.59.suppl_1.i72_bib46","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/1529-0131(200003)43:3<495::AID-ANR4>3.0.CO;2-U","article-title":"Treatment with leflunomide slows radiographic progression of rheumatoid arthritis: results from three randomized controlled trials of leflunomide in patients with active rheumatoid arthritis. Rheumatoid Arthritis Investigators Group.","volume":"43","author":"Sharp","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.59.suppl_1.i72_bib47","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/BF00297290","article-title":"Effect of calcitonin on bone histomorphometry and bone metabolism in rheumatoid arthritis.","volume":"50","author":"Kroger","year":"1992","journal-title":"Calcif Tissue Int"},{"key":"10.1136\/ard.59.suppl_1.i72_bib48","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1136\/ard.48.5.396","article-title":"Clinical, biochemical, and radiographic effects of aminohydroxypropylidene bisphosphonate treatment in rheumatoid arthritis.","volume":"48","author":"Ralston","year":"1989","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.59.suppl_1.i72_bib49","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/art.1780390307","article-title":"Increased bone mass with pamidronate treatment in rheumatoid arthritis; results of a three-year randomized double-blind trial.","volume":"39","author":"Eggelmeijer","year":"1996","journal-title":"Arthritis Rheum"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724498932?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724498932?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.59.suppl_1.i72","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T09:05:34Z","timestamp":1736154334000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724498932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,11]]},"references-count":49,"alternative-id":["S0003496724498932"],"URL":"https:\/\/doi.org\/10.1136\/ard.59.suppl_1.i72","relation":{},"ISSN":["0003-4967"],"issn-type":[{"type":"print","value":"0003-4967"}],"subject":[],"published":{"date-parts":[[2000,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The final pathogenetic steps in focal bone erosions in rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.59.suppl_1.i72","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2000 Annals of the Rheumatic Diseases, Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}